» Articles » PMID: 18996916

Disruption of Neural Progenitors Along the Ventricular and Subventricular Zones in Periventricular Heterotopia

Abstract

Periventricular heterotopia (PH) is a disorder characterized by neuronal nodules, ectopically positioned along the lateral ventricles of the cerebral cortex. Mutations in either of two human genes, Filamin A (FLNA) or ADP-ribosylation factor guanine exchange factor 2 (ARFGEF2), cause PH (Fox et al. in 'Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia'. Neuron, 21, 1315-1325, 1998; Sheen et al. in 'Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex'. Nat. Genet., 36, 69-76, 2004). Recent studies have shown that mutations in mitogen-activated protein kinase kinase kinase-4 (Mekk4), an indirect interactor with FlnA, also lead to periventricular nodule formation in mice (Sarkisian et al. in 'MEKK4 signaling regulates filamin expression and neuronal migration'. Neuron, 52, 789-801, 2006). Here we show that neurons in post-mortem human PH brains migrated appropriately into the cortex, that periventricular nodules were primarily composed of later-born neurons, and that the neuroependyma was disrupted in all PH cases. As studied in the mouse, loss of FlnA or Big2 function in neural precursors impaired neuronal migration from the germinal zone, disrupted cell adhesion and compromised neuroepithelial integrity. Finally, the hydrocephalus with hop gait (hyh) mouse, which harbors a mutation in Napa [encoding N-ethylmaleimide-sensitive factor attachment protein alpha (alpha-SNAP)], also develops a progressive denudation of the neuroepithelium, leading to periventricular nodule formation. Previous studies have shown that Arfgef2 and Napa direct vesicle trafficking and fusion, whereas FlnA associates dynamically with the Golgi membranes during budding and trafficking of transport vesicles. Our current findings suggest that PH formation arises from a final common pathway involving disruption of vesicle trafficking, leading to impaired cell adhesion and loss of neuroependymal integrity.

Citing Articles

Adherent junctions: Physiology, role in hydrocephalus and potential therapeutic targets.

Chen Z, He J, Guo Y, Hao Y, Lv W, Chen Z IBRO Neurosci Rep. 2025; 18:283-292.

PMID: 39995568 PMC: 11849119. DOI: 10.1016/j.ibneur.2025.02.003.


Neurogenesis and glial impairments in congenital hydrocephalus: insights from a BioGlue-induced fetal lamb model.

Karakaya D, Lampe K, Encinas J, Duru S, Peiro L, Oge H Fluids Barriers CNS. 2025; 22(1):20.

PMID: 39994758 PMC: 11849300. DOI: 10.1186/s12987-025-00630-3.


MAP3K4 kinase action and dual role in cancer.

Huang Y, Wang G, Zhang N, Zeng X Discov Oncol. 2024; 15(1):99.

PMID: 38568424 PMC: 10992237. DOI: 10.1007/s12672-024-00961-x.


Intraventricular dimethyl sulfoxide (DMSO) induces hydrocephalus in a dose-dependent pattern.

Castaneyra-Ruiz L, Ledbetter J, Lee S, Rangel A, Torres E, Romero B Heliyon. 2024; 10(5):e27295.

PMID: 38486744 PMC: 10937698. DOI: 10.1016/j.heliyon.2024.e27295.


A selective defect in the glial wedge as part of the neuroepithelium disruption in hydrocephalus development in the mouse hyh model is associated with complete corpus callosum dysgenesis.

Rodriguez-Perez L, Lopez-de-San-Sebastian J, de Diego I, Smith A, Roales-Bujan R, Jimenez A Front Cell Neurosci. 2024; 18:1330412.

PMID: 38450283 PMC: 10915275. DOI: 10.3389/fncel.2024.1330412.


References
1.
Banham A, Beasley N, Campo E, Fernandez P, Fidler C, Gatter K . The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res. 2001; 61(24):8820-9. View

2.
Reiner O, Carrozzo R, Shen Y, Wehnert M, Faustinella F, Dobyns W . Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature. 1993; 364(6439):717-21. DOI: 10.1038/364717a0. View

3.
Couillard-Despres S, Winkler J, Uyanik G, Aigner L . Molecular mechanisms of neuronal migration disorders, quo vadis?. Curr Mol Med. 2002; 1(6):677-88. DOI: 10.2174/1566524013363195. View

4.
Yamamoto T, Kato Y, Kawaguchi M, Shibata N, Kobayashi M . Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin. Med Electron Microsc. 2004; 37(4):200-7. DOI: 10.1007/s00795-004-0260-5. View

5.
Lanzetti L . Actin in membrane trafficking. Curr Opin Cell Biol. 2007; 19(4):453-8. DOI: 10.1016/j.ceb.2007.04.017. View